1. Home
  2. FMS vs HOLX Comparison

FMS vs HOLX Comparison

Compare FMS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$23.27

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$74.98

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMS
HOLX
Founded
1996
1985
Country
Germany
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
16.6B
IPO Year
1996
1990

Fundamental Metrics

Financial Performance
Metric
FMS
HOLX
Price
$23.27
$74.98
Analyst Decision
Sell
Hold
Analyst Count
2
15
Target Price
$30.00
$79.64
AVG Volume (30 Days)
482.1K
3.0M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
2.45%
N/A
EPS Growth
8.62
N/A
EPS
2.86
2.49
Revenue
$23,046,819,198.00
$4,100,500,000.00
Revenue This Year
$2.12
$6.69
Revenue Next Year
$2.92
$5.74
P/E Ratio
$15.86
$30.11
Revenue Growth
2.10
1.74
52 Week Low
$22.05
$51.90
52 Week High
$30.46
$80.31

Technical Indicators

Market Signals
Indicator
FMS
HOLX
Relative Strength Index (RSI) 37.10 67.93
Support Level $22.51 $74.55
Resistance Level $24.20 $75.12
Average True Range (ATR) 0.30 0.28
MACD 0.09 -0.14
Stochastic Oscillator 45.27 78.92

Price Performance

Historical Comparison
FMS
HOLX

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: